A Single‐Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities
ABSTRACT Introduction Chromosome 1q copy gains (with‐1q‐gain) is a frequently observed genetic abnormality in multiple myeloma (MM) patients. Recent research has demonstrated that 1q gain is a prognostic factor, linked to poorer clinical outcomes. Methods This study was conducted at the Princess Mar...
Saved in:
| Main Authors: | Ashish Patel, Esther Masih‐Khan, Adam Smith, Katherine Lajkosz, Sita Bhella, Christine Chen, Anca Prica, Donna Reece, A. Keith Stewart, Roger Tiedemann, Suzanne Trudel, Chloe Yang, Guido Lancman, Vishal Kukreti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | eJHaem |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jha2.70045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression
by: Jie Wei, et al.
Published: (2025-07-01) -
Multi-omics analysis reveals cancer stemness function and establishes a predictive model for thyroid cancer prognosis and immunotherapy
by: Zhanrong Feng, et al.
Published: (2025-06-01) -
Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
by: Sikander Ailawadhi, et al.
Published: (2023-02-01) -
Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure
by: Jeries Kort, et al.
Published: (2025-06-01) -
Deletion polymorphisms in the glutathione S-transferase genes are associated with the development of multiple myeloma: a meta-analysis
by: Raphael Enrique Tiongco, et al.
Published: (2025-07-01)